Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology.

Dziewas, Rainer; Allescher, Hans-Dieter; Aroyo, Ilia; Bartolome, Gudrun; Beilenhoff, Ulrike; Bohlender, Jörg; Breitbach-Snowdon, Helga; Fheodoroff, Klemens; Glahn, Jörg; Heppner, Hans-Jürgen; Hörmann, Karl; Ledl, Christian; Lücking, Christoph; Pokieser, Peter; Schefold, Jörg C; Schröter-Morasch, Heidrun; Schweikert, Kathi; Sparing, Roland; Trapl-Grundschober, Michaela; Wallesch, Claus; ... (2021). Diagnosis and treatment of neurogenic dysphagia - S1 guideline of the German Society of Neurology. Neurological research and practice, 3(1), p. 23. BioMed Central 10.1186/s42466-021-00122-3

[img]
Preview
Text
2021_-_Dziewas-_Neurol_Res_Pract_-_PMID_33941289.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

INTRODUCTION

Neurogenic dysphagia defines swallowing disorders caused by diseases of the central and peripheral nervous system, neuromuscular transmission, or muscles. Neurogenic dysphagia is one of the most common and at the same time most dangerous symptoms of many neurological diseases. Its most important sequelae include aspiration pneumonia, malnutrition and dehydration, and affected patients more often require long-term care and are exposed to an increased mortality. Based on a systematic pubmed research of related original papers, review articles, international guidelines and surveys about the diagnostics and treatment of neurogenic dysphagia, a consensus process was initiated, which included dysphagia experts from 27 medical societies.

RECOMMENDATIONS

This guideline consists of 53 recommendations covering in its first part the whole diagnostic spectrum from the dysphagia specific medical history, initial dysphagia screening and clinical assessment, to more refined instrumental procedures, such as flexible endoscopic evaluation of swallowing, the videofluoroscopic swallowing study and high-resolution manometry. In addition, specific clinical scenarios are captured, among others the management of patients with nasogastric and tracheotomy tubes. The second part of this guideline is dedicated to the treatment of neurogenic dysphagia. Apart from dietary interventions and behavioral swallowing treatment, interventions to improve oral hygiene, pharmacological treatment options, different modalities of neurostimulation as well as minimally invasive and surgical therapies are dealt with.

CONCLUSIONS

The diagnosis and treatment of neurogenic dysphagia is challenging and requires a joined effort of different medical professions. While the evidence supporting the implementation of dysphagia screening is rather convincing, further trials are needed to improve the quality of evidence for more refined methods of dysphagia diagnostics and, in particular, the different treatment options of neurogenic dysphagia. The present article is an abridged and translated version of the guideline recently published online ( https://www.awmf.org/uploads/tx_szleitlinien/030-111l_Neurogene-Dysphagie_2020-05.pdf ).

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Intensive Care, Emergency Medicine and Anaesthesiology (DINA) > Clinic of Intensive Care

UniBE Contributor:

Schefold, Jörg Christian

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2524-3489

Publisher:

BioMed Central

Language:

English

Submitter:

Jsabelle Arni

Date Deposited:

08 Jun 2021 11:44

Last Modified:

13 Jun 2021 03:09

Publisher DOI:

10.1186/s42466-021-00122-3

PubMed ID:

33941289

BORIS DOI:

10.48350/156221

URI:

https://boris.unibe.ch/id/eprint/156221

Actions (login required)

Edit item Edit item
Provide Feedback